{"version":"1.0","provider_name":"CENTOGENE","provider_url":"https:\/\/www.centogene.com\/pl","author_name":"admincg","author_url":"https:\/\/www.centogene.com\/pl\/author\/admincg\/","title":"CENTOGENE iPSC Technology Solutions to Support Disease Modeling | CENTOGENE","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"f60jjmLZhZ\"><a href=\"https:\/\/www.centogene.com\/pl\/centogene-ipsc-technology-solutions-to-support-disease-modeling\/\">Rozwi\u0105zania technologiczne CENTOGENE iPSC wspomagaj\u0105ce modelowanie chor\u00f3b<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.centogene.com\/pl\/centogene-ipsc-technology-solutions-to-support-disease-modeling\/embed\/#?secret=f60jjmLZhZ\" width=\"600\" height=\"338\" title=\"&#8222;CENTOGENE iPSC Technology Solutions to Support Disease Modeling&#8221; &#8212; CENTOGENE\" data-secret=\"f60jjmLZhZ\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.centogene.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>","description":"In a whitepaper released today, CENTOGENE provided an update on its induced pluripotent stem cells (iPSC) program. Launched in early 2019, the program is focused on supporting pharmaceutical companies for faster and cheaper orphan drug development for neurodegenerative, metabolic, and cardiovascular diseases.","thumbnail_url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","thumbnail_width":740,"thumbnail_height":416}